French Registry of Acute Coronary Syndrome (Fast-MI)

January 24, 2017 updated by: Assistance Publique - Hôpitaux de Paris

French Registry of Acute Coronary Syndrome With or Without ST Elevation

The Fast-MI registry was designed to evaluate the "real world" management of patients with acute myocardial infarction (MI), and to assess their in-hospital, medium and long-term outcomes

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Primary objectives : compare survival following the admission to a USIC according to the terms of care

Study Type

Observational

Enrollment (Actual)

3750

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Paris, France, 75012
        • French Society of Cardiology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Admitted patients in a Unit of Coronary Intensive Care (USIC) for a acute coronary syndrome

Description

Inclusion Criteria:

  • admission within the 48 hours after the occurence of acute myocardial infarction (AMI)
  • written informed consent for the DNA and serum databank

Exclusion Criteria:

  • AMI occured within the 48 hours after therapeutic intervention (bypass, coronary angioplasty or other chirurgical intervention)
  • diagnostic of AMI not confirmed

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
Adults (female and male) with a acute coronary syndrome
Other: Blood sample
60 ml of whole blood

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
All causes mortality at each follow-up period
Time Frame: 6 months, each year
6 months, each year

Secondary Outcome Measures

Outcome Measure
Time Frame
Cardiovascular mortality
Time Frame: 6 month, each year
6 month, each year
validation of guidelines across the country
Time Frame: 6 month, each year
6 month, each year
Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes
Time Frame: 6 month each year
6 month each year
Serum databank for evaluation of biomarkers in MI
Time Frame: 6 month each year
6 month each year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

French Cardiology Society

Investigators

  • Principal Investigator: Nicolas DANCHIN, MD PH, Assistance Publique - Hôpitaux de Paris

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2005

Primary Completion (Anticipated)

December 1, 2017

Study Completion (Anticipated)

June 1, 2019

Study Registration Dates

First Submitted

May 5, 2008

First Submitted That Met QC Criteria

May 5, 2008

First Posted (Estimate)

May 7, 2008

Study Record Updates

Last Update Posted (Estimate)

January 25, 2017

Last Update Submitted That Met QC Criteria

January 24, 2017

Last Verified

October 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 04-1244

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Myocardial Infarction

Clinical Trials on Blood sample

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe